DPP4 and acute respiratory distress syndrome: We recently reported that CD26/DPP4 inhibition has anti-inflammatory effects on human lung microvascular endothelial cells (HLMVECs) [17], indicating that CD26/DPP4 is involved in lung endothelial cell functions related to the pathophysiology of ARDS.